Reproterol is a short-acting beta-2 adrenergic receptor agonist used as an anti-asthma medication to manage bronchospasm associated with conditions such as asthma and chronic obstructive pulmonary disease.… Read more
Reproterol is a short-acting beta-2 adrenergic receptor agonist used as an anti-asthma medication to manage bronchospasm associated with conditions such as asthma and chronic obstructive pulmonary disease. By stimulating receptors within the airways, this compound promotes bronchodilation to relieve airway constriction. This category provides comprehensive analytical support through a range of Reproterol reference standards, including identified degradation products like N-nitroso variants and stable isotope labelled compounds. These materials are essential for rigorous impurity profiling, method validation, and routine quality control during pharmaceutical development. By utilizing deuterated standards as internal markers in mass spectrometry, researchers can achieve precise quantification and reliable analytical data. Access to these specialized compounds ensures that laboratory workflows for testing the active pharmaceutical ingredient remain consistent with established regulatory requirements for purity and safety.